CRIS Current Research Information System

BIASCO, GUIDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.665
EU - Europa 10.504
AS - Asia 5.630
AF - Africa 687
SA - Sud America 44
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 9
Totale 32.565
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.599
GB - Regno Unito 3.386
CN - Cina 2.140
VN - Vietnam 1.396
SE - Svezia 1.314
DE - Germania 1.279
IT - Italia 1.273
SG - Singapore 1.239
IN - India 599
IE - Irlanda 541
CH - Svizzera 520
UA - Ucraina 516
RU - Federazione Russa 489
FR - Francia 419
ZA - Sudafrica 275
EE - Estonia 246
TG - Togo 225
FI - Finlandia 126
BG - Bulgaria 97
JO - Giordania 93
NG - Nigeria 74
CI - Costa d'Avorio 69
BE - Belgio 67
CA - Canada 62
AT - Austria 49
GR - Grecia 42
IR - Iran 41
SC - Seychelles 33
NL - Olanda 32
AU - Australia 22
JP - Giappone 21
BR - Brasile 19
CL - Cile 18
ID - Indonesia 18
PL - Polonia 18
RO - Romania 18
HR - Croazia 17
LB - Libano 15
HK - Hong Kong 14
MY - Malesia 12
CZ - Repubblica Ceca 10
PT - Portogallo 10
TR - Turchia 10
SK - Slovacchia (Repubblica Slovacca) 8
A2 - ???statistics.table.value.countryCode.A2??? 7
ES - Italia 7
UZ - Uzbekistan 7
LT - Lituania 6
IL - Israele 5
KR - Corea 5
EC - Ecuador 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
SA - Arabia Saudita 4
DZ - Algeria 3
HU - Ungheria 3
MU - Mauritius 3
MX - Messico 3
CM - Camerun 2
DK - Danimarca 2
EG - Egitto 2
EU - Europa 2
KZ - Kazakistan 2
LU - Lussemburgo 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BD - Bangladesh 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
JM - Giamaica 1
LK - Sri Lanka 1
MC - Monaco 1
MD - Moldavia 1
MN - Mongolia 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
SM - San Marino 1
TH - Thailandia 1
TN - Tunisia 1
Totale 32.565
Salva come PNG Salva come JPEG
Città #
Southend 3.142
Fairfield 1.888
Chandler 1.488
Ashburn 1.171
Singapore 1.100
Woodbridge 937
Wilmington 929
Houston 872
Dong Ket 821
Seattle 786
Santa Clara 750
Princeton 690
Cambridge 627
Ann Arbor 584
Bern 499
Dublin 487
Boardman 380
Jacksonville 302
Nanjing 300
Westminster 296
Padova 282
Bologna 264
Lomé 225
New York 199
Berlin 177
Jinan 163
Beijing 155
Saint Petersburg 140
Shenyang 140
Helsinki 125
San Diego 120
Medford 119
Menlo Park 112
Nanchang 101
Sofia 97
Changsha 96
Amman 93
Hebei 91
Turin 88
Mülheim 86
Jiaxing 82
Abeokuta 73
Abidjan 69
Tianjin 61
Dearborn 60
Milan 60
Brussels 59
Falls Church 59
Florence 58
Hangzhou 54
Redmond 54
Des Moines 53
Guangzhou 50
Kuban 49
Los Angeles 49
Norwalk 48
Zhengzhou 48
Bremen 45
Toronto 43
Taiyuan 42
Shanghai 41
Taizhou 40
Fremont 36
Olalla 35
Redwood City 35
Vienna 35
Haikou 34
Bühl 33
Mahé 33
Ningbo 33
Lanzhou 32
Kunming 30
San Venanzo 28
Phoenix 27
Pune 26
London 23
Mountain View 23
Wuhan 22
Hefei 20
Paris 20
Monmouth Junction 19
Fuzhou 18
Hyderabad 18
San Francisco 18
Tokyo 18
Verona 18
Ardabil 16
Frankfurt am Main 16
Jakarta 16
Rome 16
São Paulo 16
Leawood 15
Warsaw 15
Zanjan 14
Falkenstein 13
Xi'an 13
Chicago 12
Frankfurt Am Main 12
Moscow 12
Shenzhen 12
Totale 22.951
Salva come PNG Salva come JPEG
Nome #
The National Tumor Association Foundation (ANT): A 30 year old model of home palliative care. 472
Asbestos: a hidden player behind the cholangiocarcinoma increase? Findings from a case–control analysis 339
A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and high-resolution genomic copy number. 211
A phase I study of continuous hepatic arterial infusion of Irinotecan in patients with locally advanced hepatocellular carcinoma. 197
Circadian variations of rectal cell proliferation in patients affected by advanced colorectal cancer. 195
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases. 194
Adjuvant chemotherapy for resected colorectal cancer metastases: literature revision and meta-analysis 194
Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array 191
Characterization of pancreatic ductal adenocarcinoma patients using whole-transcriptome sequencing and copy number analysis by SNPs array techniques. 188
Antitumoral efficacy of the protease inhibitor gabexate mesilate in colon cancer cells harbouring KRAS, BRAF and PIK3CA mutations 186
Cardiac metastasis of melanoma. 183
Antiprotease strategy in combination with gemcitabine as a putative novel therapeutic approach for pancreatic cancer treatment 183
CLINICOPATHOLOGICAL, MOLECULAR AND ONCOLOGICAL FEATURES OF SPORADIC EARLY ONSET COLORECTAL CANCERS 180
Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST. 180
The 'surprise' question in advanced cancer patients: A prospective study among general practitioners. 176
A distinct pediatric-type gastrointestinal stromal tumor in adults: potential role of succinate dehydrogenase subunit A mutations. 176
219 MiR-21 expression correlates with prognosis in extrahepatic radically resected cholangiocarcinomas treated with gemcitabine-based adjuvant chemotherapy 175
Chronic therapy in gastrointestinal stromal tumours (GISTs): the big gap between theory and practice 173
Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study. 173
D32Left versus right side primary tumor: the correlation with clinical outcome of patients with resected stage II and III colorectal cancer 171
Brain Metastases from Biliary Tract Cancer: A Monocentric Retrospective Analysis of 450 Patients 171
Concurrent EGFr and Cox-2 expression in colorectal cancer: proliferation impact and tumour spreading 170
Autoimmune pancreatitis associated with high levels of chromogranin a, serotonin and 5-hydroxyindoleacetic Acid 169
Chemotherapy followed by chemoradiotherapy in locally advanced pancreatic cancer:A literature review and report of two cases 169
Fulminant hepatitis in a patient with hepatocellular carcinoma related to nonalcoholic steatohepatitis treated with sorafenib. 162
Alternative schedules or integration strategies to maximise treatment duration with sunitinib in patients with gastrointestinal stromal tumours. 162
An exploratory association of polymorphisms in angiogenesis-related genes with susceptibility, clinical response and toxicity in gastrointestinal stromal tumors receiving sunitinib after imatinib failure 161
Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model. 161
Complete remission of primary colon cancer in a metastatic patient treated with CPT-11 plus capecitabine. 159
Comparing recist and Choi’s criteria to evaluate radiological response to chemotherapy in patients with advanced pancreatic cancer 157
Aspirin for cholangiocarcinoma prevention: New targets to shift the dogma from ascertained risk to possible prevention 154
Combined treatment strategies in gastrointestinal stromal tumors (GISTs) after imatinib and sunitinib therapy. 153
Cell proliferation and ultrastructural changes of the duodenal mucosa of patients affected by familial adenomatous polyposis. 153
Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations 151
Development of a Nephrotic Syndrome in a Patient with Gastrointestinal Stromal Tumor during a Long-Time Treatment with Sunitinib. 150
Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, predicts a poor prognosis. 150
Genome-wide analysis identifies MEN1 and MAX mutations and a neuroendocrine-like molecular heterogeneity in Quadruple WT GIST 150
HIV enteropathy: undescribed ultrastructural changes of duodenal mucosa and their regression after triple antiviral therapy. A case report 149
ACTIVATED NF-KB IN COLORECTAL CANCER: PREDICTIVE OR PROGNOSTIC FACTOR? 149
Mutational burden of resectable pancreatic cancer by whole-transcriptome and whole-exome sequencing could predict a poor prognosis 149
Can the tyrosine kinase inhibitors trigger metabolic encephalopathy in cirrhotic patients? 148
Asbestos: a putative risk factor for intrahepatic cholangiocarcinoma 147
High thymidylate synthase expression in colorectal cancer with microsatellite instability: implications for chemotherapeutic strategies. 145
Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases. 145
Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients 144
Risk of duodenal adenomas in familial adenomatous polyposis to progress toward advanced neoplastic disease 143
MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. 143
Mechanisms of secondary resistance to tyrosine kinase inhibitors in gastrointestinal stromal tumours (Review). 143
Clinical, radiological and biological features of lung metastases in gastrointestinal stromal tumors (case reports). 143
Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST) 142
Copy number gain of chromosome 3q is a recurrent event in patients with intraductal papillary mucinous neoplasm (IPMN) associated with disease progression 142
Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST) 142
Severe esophagitis in a patient with gastrointestinal stromal tumor treated with imatinib. 141
Late recurrences of gastrointestinal stromal tumours (GISTs) after 5 years of follow-up. 141
Venous thromboembolism and port-related thrombosis in metastatic colorectal cancer patients: a monocenter experience. 140
11C-acetate PET for early prediction of sunitinib response in metastatic renal cell carcinoma. 139
Whole Exome Sequencing Uncovers Germline Variants of Cancer-Related Genes in Sporadic Pheochromocytoma 139
Neoadjuvant therapy for resectable pancreatic adenocarcinoma: An interim report of a prospective randomized study 135
Duration of adjuvant treatment following radical resection of metastases from gastrointestinal stromal tumours. 135
An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor 135
An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST) 135
Molecular imaging suggests efficacy of bevacizumab beyond the second line in advanced colorectal cancer patients. 133
Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice 133
Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET. 133
TERC and c-MYC COPY number gain in intraductal papillary mucinous neoplasms (IPMNs): promising biomarkers of progression to malignancy 133
Genetic heterogeneity in cholangiocarcinoma: a major challenge for targeted therapies 133
Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice 132
Integrated Molecular Characterization of Gastrointestinal Stromal Tumors (GIST) Harboring the Rare D842V Mutation in PDGFRA Gene. 132
Differential expression of neural markers in KIT and PDGFRA wild-type gastrointestinal stromal tumours. 131
An online international comparison of thresholds for triggering a negative response to the "Surprise Question": a study protocol 130
Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib 129
Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer 127
Insulin-like growth factor 1 receptor expression in wild-type GISTs: a potential novel therapeutic target. 127
Integrating miRNA and gene expression profiling analysis revealed regulatory networks in gastrointestinal stromal tumors 126
HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma 126
Occupational exposure to asbestos and risk of cholangiocarcinoma: a population-based case-control study in four Nordic countries 125
MicroRNA profile in gastrointestinal stromal tumors (GISTs) and correlation with KIT/PDGFRA kinase genotype. 125
Spontaneous regression of a desmoid intraabdominal tumor in a patient affected by familial adenomatous polyposis. 124
Treatment of colorectal cancer liver metastases 124
Molecular Imaging of EGFR: It's Time to Go Beyond Receptor Expression 124
GemOx and Ovarian Pancreatic Cancer Metastasis (PC) 124
Evaluation of Modified PEG-Anilinoquinazoline Derivatives as Potential Agents for EGFR Imaging in Cancer by Small Animal PET. 124
Laparoscopic treatment of gastric GIST: report of 21 cases and literature's review. 124
Advanced pancreatic cancer (APC) A monocenter experience in 53 patients: is it possible a second line treatment? 124
Cell proliferation and differentiation in familial adenomatous polyposis (FAP). 123
Successful treatment with personalized dosage of imatinib in elderly patients with gastrointestinal stromal tumors 123
In Reply 123
An immunohistochemical study of potential diagnostic and therapeutic biomarkers of wild type gastrointestinal stromal tumours - Letter to the editor. 121
Efficacy of weekly docetaxel in locally advanced cardiac angiosarcoma 121
Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives. 120
Genomic And Genetic Characterization of Cholangiocarcinoma Identifies Therapeutics Targets for Tyrosine Kinase Inhibitors 119
La comunicazione con il paziente al termine della vita 119
Intestinal microflora and digestive toxicity of irinotecan in mice. 119
CIRCULATING METALLOPROTEINASE-3 AND TISSUE INHIBITOR OF METALLOPROTEINASE-2 IN PATIENTS WITH DUCTAL PANCREATIC NEOPLASMS 118
Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors 118
Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunction. 118
Personalized Medicine in Gastrointestinal Stromal Tumor (GIST): Clinical Implications of the Somatic and Germline DNA Analysis 118
Microscopic margins of resection influence primary gastrointestinal stromal tumor survival. 118
Routine duodenal biopsies: is it time to change our minds? 117
Urease-Positive Bacteria Other than Helicobacter pylori in Human Gastric Juice and Mucosa 116
Totale 15.107
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.266
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.266
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.488 0 0 0 0 0 0 990 1.048 1.060 521 373 496
2020/20214.523 908 300 136 194 51 245 54 228 488 192 191 1.536
2021/20226.010 614 258 322 437 527 299 152 349 279 424 1.272 1.077
2022/20236.568 740 950 334 814 384 418 144 387 1.026 192 524 655
2023/20241.666 165 276 71 190 132 419 77 109 45 87 51 44
2024/20253.585 207 967 476 430 1.215 289 1 0 0 0 0 0
Totale 33.380